Dual and opposite roles of reactive oxygen species (ROS) in Chagas disease: beneficial on the pathogen and harmful on the host

E Maldonado, DA Rojas, S Morales… - Oxidative Medicine …, 2020 - Wiley Online Library
Chagas disease is a neglected tropical disease, which affects an estimate of 6‐7 million
people worldwide. Chagas disease is caused by Trypanosoma cruzi, which is a eukaryotic …

How Trypanosoma cruzi deals with oxidative stress: Antioxidant defence and DNA repair pathways

A Machado-Silva, PG Cerqueira… - … Research/Reviews in …, 2016 - Elsevier
Trypanosoma cruzi, the causative agent of Chagas disease, is an obligatory intracellular
parasite with a digenetic life cycle. Due to the variety of host environments, it faces several …

Current therapeutics, their problems and thiol metabolism as potential drug targets in leishmaniasis

K Singh, G Garg, V Ali - Current drug metabolism, 2016 - ingentaconnect.com
Leishmaniasis is one of the six diseases regarded most neglected by World Health
Organization which is predominant in developing countries. Clinically, among the different …

Redox Balance Keepers and Possible Cell Functions Managed by Redox Homeostasis in Trypanosoma cruzi

AC Mesías, NJ Garg, MP Zago - Frontiers in Cellular and Infection …, 2019 - frontiersin.org
The toxicity of oxygen and nitrogen reactive species appears to be merely the tip of the
iceberg in the world of redox homeostasis. Now, oxidative stress can be seen as a two-sided …

Trypanosoma cruzi pathogenicity involves virulence factor expression and upregulation of bioenergetic and biosynthetic pathways

J San Francisco, C Astudillo, JL Vega, A Catalán… - Virulence, 2022 - Taylor & Francis
The molecular repertoire of Trypanosoma cruzi effects its virulence and impacts the clinical
course of the resulting Chagas disease. This study aimed to determine the mechanism …

Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum

AF Sousa, AG Gomes-Alves, D Benítez… - Free Radical Biology …, 2014 - Elsevier
Trypanothione is a unique and essential redox metabolite of trypanosomatid parasites, the
biosynthetic pathway of which is regarded as a promising target for antiparasitic drugs …

Trypanothione metabolism as drug target for trypanosomatids

MD Piñeyro, D Arias, A Parodi-Talice… - Current …, 2021 - ingentaconnect.com
Chagas Disease, African sleeping sickness, and leishmaniasis are neglected diseases
caused by pathogenic trypanosomatid parasites, which have a considerable impact on …

Targets and patented drugs for chemotherapy of Chagas disease in the last 15 years-period

V G. Duschak - Recent patents on anti-infective drug discovery, 2016 - benthamdirect.com
Background: The American trypanosomiasis, Chagas disease, is a parasitic infection
typically spread by triatomine vectors affecting millions of people all over Latin America …

Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase

SS Suman, A Equbal, A Zaidi, MY Ansari, KP Singh… - Biochimie, 2016 - Elsevier
Leishmania is a unicellular protozoan parasite which causes leishmaniasis, a neglected
tropical disease. It possess a unique thiol metabolism comprising of several proteins among …

Discovery and genetic validation of chemotherapeutic targets for Chagas' disease

JF Osorio-Méndez, AM Cevallos - Frontiers in cellular and infection …, 2019 - frontiersin.org
There is an urgent need to develop new treatments for Chagas' disease. To identify drug
targets, it is important to understand the basic biology of Trypanosoma cruzi, in particular …